Clinical development of liposome based drugs: formulation, characterization, and therapeutic efficacy

Hsin-I Chang1, Ming-Kung Yeh21Department of Biochemical Science and Technology, National Chia Yi University, Chiayi City, 2Institute of Preventive Medicine, National Defence Medical Center, Sanhsia, Taipei, TaiwanAbstract: Research on liposome formulations has progressed from that on conventional ve...

Full description

Bibliographic Details
Main Authors: Chang HI, Yeh MK
Format: Article
Language:English
Published: Dove Medical Press 2011-12-01
Series:International Journal of Nanomedicine
Online Access:http://www.dovepress.com/clinical-development-of-liposome-based-drugs-formulation-characterizat-a8980
id doaj-2011e8e45ba8406c8ba63568a056f627
record_format Article
spelling doaj-2011e8e45ba8406c8ba63568a056f6272020-11-24T23:53:36ZengDove Medical PressInternational Journal of Nanomedicine1176-91141178-20132011-12-012012default4960Clinical development of liposome based drugs: formulation, characterization, and therapeutic efficacyChang HIYeh MKHsin-I Chang1, Ming-Kung Yeh21Department of Biochemical Science and Technology, National Chia Yi University, Chiayi City, 2Institute of Preventive Medicine, National Defence Medical Center, Sanhsia, Taipei, TaiwanAbstract: Research on liposome formulations has progressed from that on conventional vesicles to new generation liposomes, such as cationic liposomes, temperature sensitive liposomes, and virosomes, by modulating the formulation techniques and lipid composition. Many research papers focus on the correlation of blood circulation time and drug accumulation in target tissues with physicochemical properties of liposomal formulations, including particle size, membrane lamellarity, surface charge, permeability, encapsulation volume, shelf time, and release rate. This review is mainly to compare the therapeutic effect of current clinically approved liposome-based drugs with free drugs, and to also determine the clinical effect via liposomal variations in lipid composition. Furthermore, the major preclinical and clinical data related to the principal liposomal formulations are also summarized.Keywords: PEGlated liposomes, temperature sensitive liposomes, therapeutic efficiency, virosomes, cationic liposomeshttp://www.dovepress.com/clinical-development-of-liposome-based-drugs-formulation-characterizat-a8980
collection DOAJ
language English
format Article
sources DOAJ
author Chang HI
Yeh MK
spellingShingle Chang HI
Yeh MK
Clinical development of liposome based drugs: formulation, characterization, and therapeutic efficacy
International Journal of Nanomedicine
author_facet Chang HI
Yeh MK
author_sort Chang HI
title Clinical development of liposome based drugs: formulation, characterization, and therapeutic efficacy
title_short Clinical development of liposome based drugs: formulation, characterization, and therapeutic efficacy
title_full Clinical development of liposome based drugs: formulation, characterization, and therapeutic efficacy
title_fullStr Clinical development of liposome based drugs: formulation, characterization, and therapeutic efficacy
title_full_unstemmed Clinical development of liposome based drugs: formulation, characterization, and therapeutic efficacy
title_sort clinical development of liposome based drugs: formulation, characterization, and therapeutic efficacy
publisher Dove Medical Press
series International Journal of Nanomedicine
issn 1176-9114
1178-2013
publishDate 2011-12-01
description Hsin-I Chang1, Ming-Kung Yeh21Department of Biochemical Science and Technology, National Chia Yi University, Chiayi City, 2Institute of Preventive Medicine, National Defence Medical Center, Sanhsia, Taipei, TaiwanAbstract: Research on liposome formulations has progressed from that on conventional vesicles to new generation liposomes, such as cationic liposomes, temperature sensitive liposomes, and virosomes, by modulating the formulation techniques and lipid composition. Many research papers focus on the correlation of blood circulation time and drug accumulation in target tissues with physicochemical properties of liposomal formulations, including particle size, membrane lamellarity, surface charge, permeability, encapsulation volume, shelf time, and release rate. This review is mainly to compare the therapeutic effect of current clinically approved liposome-based drugs with free drugs, and to also determine the clinical effect via liposomal variations in lipid composition. Furthermore, the major preclinical and clinical data related to the principal liposomal formulations are also summarized.Keywords: PEGlated liposomes, temperature sensitive liposomes, therapeutic efficiency, virosomes, cationic liposomes
url http://www.dovepress.com/clinical-development-of-liposome-based-drugs-formulation-characterizat-a8980
work_keys_str_mv AT changhi clinicaldevelopmentofliposomebaseddrugsformulationcharacterizationandtherapeuticefficacy
AT yehmk clinicaldevelopmentofliposomebaseddrugsformulationcharacterizationandtherapeuticefficacy
_version_ 1725468899439280128